ST - Sensata Technologies Holding plc

NYSE - NYSE Delayed Price. Currency in USD
47.80
+0.11 (+0.23%)
At close: 4:04PM EDT

47.82 +0.02 (0.04%)
After hours: 4:26PM EDT

Stock chart is not supported by your current browser
Previous Close 47.76
Open 47.92
Bid 47.30 x 1100
Ask 52.00 x 1000
Day's Range 47.62 - 48.10
52 Week Range 40.78 - 56.28
Volume 780,146
Avg. Volume 1,008,543
Market Cap 7.847B
Beta (3Y Monthly) 1.10
PE Ratio (TTM) 13.54
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire 28 days ago

    Sensata Technologies to Present at Barclays Industrial Select Conference

    SWINDON, United Kingdom, Feb. 18, 2019 -- Sensata Technologies (NYSE: ST) today announced that Martha Sullivan, CEO, will present at the Barclays Industrial Select Conference.

  • GlobeNewswire last month

    Sensata Technologies Reports Fourth Quarter and Full Year 2018 Financial Results

    SWINDON, United Kingdom, Feb. 06, 2019 -- Sensata Technologies (NYSE: ST), a global industrial technology company and a leading provider of sensors, today announced financial.

  • GlobeNewswire 2 months ago

    Sensata Technologies Announces the Appointment of John Absmeier to the Board of Directors & Promotion of Jeff Cote to President

    Sensata Technologies (ST), an industrial technology company and a leading provider of sensors, today announced that John Absmeier, Chief Technology Officer of Lear Corporation, has been appointed to serve as a director on Sensata’s Board of Directors and to serve on the Growth & Innovation Committee of the Board, each effective March 1, 2019. As Chief Technology Officer of Lear Corporation, Mr. Absmeier leads all aspects of Lear’s technology and innovation efforts, reporting to the company’s President and Chief Executive Officer.

  • GlobeNewswire 2 months ago

    Sensata Technologies Announces Date and Time of Fourth Quarter and Full Year 2018 Earnings Release and Webcast

    SWINDON, United Kingdom, Jan. 15, 2019 -- Sensata Technologies (NYSE:ST) today announced that it will disclose its fourth quarter and full year 2018 financial results on.

  • GlobeNewswire 2 months ago

    Sensata Technologies Foundation Announces 2018-2019 Grants & Opens 2019-2020 Grant Cycle

    The Sensata Technologies Foundation, launched in November 2017, announced its first annual grant award recipients for funding year 2019. The Foundation also announced that the grant application for the 2019-2020 grant cycle is now available on the Sensata Foundation website and will close on Friday, June 28, 2019.  The Sensata Foundation’s Annual Grants are 12-month grants for new or existing projects related to one or more of the Foundation’s priorities of STEM and Community.

  • GlobeNewswire 5 months ago

    Sensata Technologies Reports Third Quarter 2018 Financial Results

    SWINDON, United Kingdom, Oct. 30, 2018 -- Sensata Technologies (NYSE:ST), a global industrial technology company and a leading provider of sensors, today announced financial.

  • GlobeNewswire 7 months ago

    MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP

    Medical Prognosis Institute A/S and Oncology Venture AB (ST) ("OV" or the "Company") and Oncology Venture US Inc today announced that the US Food and Drug Administration (FDA) has accepted its Investigational Device Exemption (IDE) and its Investigational New Drug Application (IND) to begin a Phase 2 clinical trial in advanced ovarian cancer with 2X-121 -a PARP inhibitor- using it`s Drug Response Predictor - DRP - to select patients with high likelihood of responding to the treatment.   The 2X-121 DRP has a gene signature consisting of more than 400 genes.

  • ACCESSWIRE 8 months ago

    Sensata Technologies Holding plc to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 24, 2018 / Sensata Technologies Holding plc (NYSE: ST ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 24, 2018 at 8:00 AM Eastern ...

  • GlobeNewswire 9 months ago

    MPI: Orphan Drug designation on Oncology Venture's dovitinib for Adenoid Cystic Carcinoma

    Hoersholm, Denmark, June 28, 2018 -Medical Prognosis Institute A/S (ST) and Oncology Venture AB (ST) announces that the Office of Orphan Products Development at the FDA has transferred the Dovitinib Orphan drug designation for the treatment of adenoid cystic carcinoma to Oncology Venture from Novartis. Dovitinib is an oral available phase 3 multi Tyrosine Kinase Inhibitor (previously TKI258), for which OV holds the exclusive global rights for development and commercialization. OV is developing the dovitinib Drug Response predictor DRP® based on existing data from patient`s biopsies and clinical outcome.

  • GlobeNewswire 9 months ago

    MPI: First Patient dosed in Phase 2 Study of the PARP Inhibitor 2X-121 for Breast Cancer

    Medical Prognosis Institute A/S (ST), Oncology Venture AB (ST) and Oncology Venture US Inc. (former 2X Oncology Inc.) announces dosing of the first patient in a Phase 2, clinical study to investigate the anti-tumor effect and tolerability of 2X-121 in patients with metastatic breast cancer selected by a novel drug response predictor (DRP®) mRNA driven multiple biomarker, the 2X-121 DRP®. 2X-121 is a PARP inhibitor. This clinical trial will enroll metastatic Breast Cancer patients , who have relapsed on two or more different prior therapies.

  • ACCESSWIRE 9 months ago

    Today’s Free Research Reports Coverage on Trimble and Three More Scientific & Technical Instruments

    Ahead of today's trading session, WallStEquities.com has selected the following stocks for monitoring: MKS Instruments Inc. (NASDAQ: MKSI), Orbotech Ltd (NASDAQ: ORBK), Sensata Technologies Holding PLC (NYSE: ST), and Trimble Inc. (NASDAQ: TRMB). All you have to do is sign up today for this free limited time offer by clicking the link below.

  • ACCESSWIRE 10 months ago

    Free Research Reports on Trimble and Three More Scientific & Technical Instruments Stocks

    On Thursday, May 10, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended Thursday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Scientific & Technical Instruments equities this morning: Keysight Technologies Inc. (NYSE: KEYS), MKS Instruments Inc. (NASDAQ: MKSI), Sensata Technologies Holding PLC (NYSE: ST), and Trimble Inc. (NASDAQ: TRMB).